Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rheumatoid lung disease.

Kevin K Brown1

  • 1Department of Medicine, National Jewish Medical and Research Center, University of Colorado Health Sciences Center, Denver, Colorado, USA. brownk@njc.org

Proceedings of the American Thoracic Society
|August 9, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Continued Nintedanib Treatment in Children and Adolescents With Fibrosing ILDs: Data From InPedILD-ON.

Pediatric pulmonology·2026
Same author

Rheumatoid arthritis-associated interstitial lung disease: screening, diagnosis, and treatment-an expert group consensus statement.

The Lancet. Respiratory medicine·2026
Same author

Idiopathic pulmonary fibrosis risk loci in East Asian populations mirror those of European populations.

American journal of respiratory and critical care medicine·2026
Same author

Prognostic biomarkers for idiopathic pulmonary fibrosis: findings from ISABELA clinical trials.

ERJ open research·2026
Same author

Switch-like methylation of functional pathways distinguishes COPD and idiopathic pulmonary fibrosis.

medRxiv : the preprint server for health sciences·2025
Same author

One-Year Change in Quantitative Computed Tomography Is Associated with Meaningful Outcomes in Fibrotic Lung Disease.

American journal of respiratory and critical care medicine·2025

Rheumatoid arthritis (RA) can severely impact lungs, causing RA-associated interstitial lung disease (RA-ILD). More research is crucial to understand RA-ILD

Area of Science:

  • Rheumatology and Pulmonology
  • Immunology and Inflammation
  • Translational Medicine

Background:

  • Rheumatoid arthritis (RA) is a prevalent autoimmune disease affecting joints and leading to significant disability.
  • Pulmonary involvement is common in RA, contributing substantially to morbidity and mortality.
  • RA-associated interstitial lung disease (RA-ILD) is a major complication, impacting airways, vasculature, parenchyma, and pleura.

Discussion:

  • RA-ILD involves inflammation and fibrosis, progressively worsening patient outcomes and quality of life.
  • Current understanding of RA-ILD pathobiology and the effects of immunomodulatory therapies is limited.
  • Pulmonary infections and drug toxicity are known complications, but direct RA-related lung disease is more frequent.

Key Insights:

Related Experiment Videos

  • Progressive lung fibrosis in RA-ILD significantly shortens survival and impairs quality of life.
  • The precise clinical impact of RA-ILD is still being fully elucidated.
  • The role of current and novel biologic therapies in managing RA-ILD remains largely unknown.

Outlook:

  • Urgent need for translational studies investigating RA-ILD pathobiology.
  • Clinical studies are required to evaluate the efficacy of existing and emerging therapies for RA-ILD.
  • Further research is essential to improve the management and outcomes for patients with RA-ILD.